Premium
Cytokinetics Inc (CYTK)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, ... Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.77 | -8.01445578231 | 47.04 | 48.54 | 41.92 | 1603752 | 44.6605574 | CS |
| 4 | -7.12 | -14.1297876563 | 50.39 | 51.74 | 40.65 | 2100462 | 45.46235092 | CS |
| 12 | -7.02 | -13.959037582 | 50.29 | 52.8 | 40.65 | 1504394 | 46.8283577 | CS |
| 26 | -12.92 | -22.9934151984 | 56.19 | 59.39 | 40.65 | 1321087 | 50.0741573 | CS |
| 52 | -24.02 | -35.6962401546 | 67.29 | 75.71 | 40.65 | 1593491 | 55.15113125 | CS |
| 156 | 7.26 | 20.1610663705 | 36.01 | 110.25 | 25.98 | 1490001 | 53.214995 | CS |
| 260 | 28.49 | 192.760487145 | 14.78 | 110.25 | 8 | 1341340 | 43.64939947 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
